Skip to main content
# Title Research Member Research Year
121 Concurrent Boost with Adjuvant Breast Hypofractionated Radiotherapy and Toxicity Assessment Dr. Alia Mohamed Ali Attia 2015
122 Comparison of Breast Sequential and Simultaneous Integrated Boost Using the Biologically Effective Dose Volume Histogram (BEDVH) Dr. Moamen Mohamed Omran Moustafa Aly 2015
123 18F-FDG PET/CT Outperforms Contrast Enhanced CT in the Diagnosis of Peritoneal Metastases from Ovarian Tumors. Dr. Yasser Gaber Ali Abdelhafez 2015
124 Chemoradiation Compared to Surgery Alone in Patients With Non-Metastatic Esophageal Carcinoma Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
125 18F-FDG PET/CT Outperforms Contrast Enhanced CT in the Diagnosis of Peritoneal Metastases from Ovarian Tumors. Dr. Yasser Gaber Ali Abdelhafez 2015
126 Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. Dr. Yasser Gaber Ali Abdelhafez 2015
127 Non-neoplastic variants of the sternum:SPECT/ CT findings Dr. Yasser Gaber Ali Abdelhafez 2015
128 Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. Dr. Yasser Gaber Ali Abdelhafez 2015
129 Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer Dr. Moamen Mohamed Omran Moustafa Aly 2014
130 A Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation Dr. Alia Mohamed Ali Attia 2014